Wanhua Chemical Secures Key Patent for High-Purity Lactide Catalyst Streamlines PLA Production Process
Wanhua Chemical has recently been granted a pivotal invention patent for a novel catalyst used in the synthesis of lactide from lactic acid, with broad implications for the biodegradable plastics industry. The technology addresses long-standing bottlenecks in producing high-quality polylactic acid (PLA), a leading sustainable polymer.
Traditional PLA production faces two main challenges: direct dehydration-polymerization yields low-molecular-weight products due to water removal difficulties, while the two-step lactide route is limited by impurities and catalyst toxicity. Wanhua’s breakthrough involves an organometallic complex catalyst containing aminopyridine and alkoxy groups, built around biocompatible metals such as calcium, magnesium, or zinc.
This catalyst offers high optical purity in lactide synthesis and significantly reduces residual lactic acid—often a major hurdle in industrial production. Its structure allows rapid interaction with lactic acid, enhancing efficiency and shortening reaction times. Unlike conventional metal salt catalysts, it avoids product contamination and is easily regenerated.
Notably, the new design also solves problems of catalyst precipitation and hydrolysis, ensuring both stability and solubility during scale-up. The result is a more streamlined, energy-saving process that delivers high-performance PLA with fewer purification steps. Wanhua’s innovation promises to accelerate green material adoption and boost the competitiveness of bio-based plastics.
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
$14.5 Billion Solstice–Element Solutions Merger Abruptly Terminated Less Than Two Months After Announcement
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Westlake to Shut Cologne PVC Plant in $205M Exit
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Wanhua Chemical Expands TPU Production by 200,000 Tons with RMB 287 Million Investment
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
Recommend Reading
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
November Refinery Petroleum Coke Market Trends Decline
-
November Maleic Anhydride Prices Generally Decline in China
-
Premium Global Chemical Sourcing Requests (1-5 Dec 2025)
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Premium Global Chemical Sourcing Requests (24-27Sep.,2026)